Role of Proglucagon Peptides in Osmoregulation
- 31 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bulletin of Experimental Biology and Medicine
- Vol. 170 (5), 1-5
- https://doi.org/10.1007/s10517-021-05118-2
Abstract
Glucagon-like peptide-1 (GLP-1), a product of partial proteolysis of proglucagon, is involved not only in regulation of carbohydrates, but also in water-salt metabolism. The study examined the role of proglucagon derivatives GLP-1, GLP-2, and oxyntomodulin in rat osmoregulation. Of them, only blood plasma GLP-1 increased in response to water load (20 ml/kg). Administration of glucose (1.5 g/kg) elevated GLP-1 and oxyntomodulin but did not change the level of GLP-2. GLP-1 accelerated excretion of excess water during hyperhydration, whereas GLP-2 decreased this parameter. No physiological effects of oxyntomodulin in the kidneys were revealed. Probably, the blood levels of proglucagon derivatives are independently regulated for each peptide. In contrast to GLP-2 and oxyntomodulin, GLP-1 is involved in osmoregulation.Keywords
This publication has 12 references indexed in Scilit:
- The Cascade System of Osmotic Homeostasis RegulationDoklady Biological Sciences, 2020
- Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic propertiesBioorganic Chemistry, 2019
- Discovery, characterization, and clinical development of the glucagon-like peptidesJCI Insight, 2017
- The mechanism of glucagon-like peptide-1 participation in the osmotic homeostasisDoklady Biological Sciences, 2016
- GLP-2: What do we know? What are we going to discover?Regulatory Peptides, 2014
- Physiological mechanisms for the increase in renal solute‐free water clearance by a glucagon‐like peptide‐1 mimeticClinical and Experimental Pharmacology and Physiology, 2013
- Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug ScreeningMolecular Pharmacology, 2010
- The Glucagon-Like Peptide-1 Receptor Agonist Oxyntomodulin Enhances β-Cell Function but Does Not Inhibit Gastric Emptying in MiceEndocrinology, 2008
- Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor β-Arrestin Recruitment and Signaling through GαThe Journal of pharmacology and experimental therapeutics, 2007
- New frontiers in the biology of GLP-2Regulatory Peptides, 2000